Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
57.53
Dollar change
-1.96
Percentage change
-3.29
%
Index- P/E- EPS (ttm)-1.14 Insider Own0.98% Shs Outstand181.36M Perf Week-5.83%
Market Cap10.44B Forward P/E528.38 EPS next Y0.11 Insider Trans-3.88% Shs Float179.75M Perf Month-10.42%
Income-204.15M PEG- EPS next Q-0.48 Inst Own89.92% Short Float4.06% Perf Quarter-11.68%
Sales2.50B P/S4.18 EPS this Y20.82% Inst Trans-1.75% Short Ratio4.00 Perf Half Y-31.99%
Book/sh17.34 P/B3.32 EPS next Y112.17% ROA-3.00% Short Interest7.29M Perf Year-11.03%
Cash/sh4.28 P/C13.43 EPS next 5Y- ROE-6.60% 52W Range58.33 - 100.77 Perf YTD-22.24%
Dividend Est.- P/FCF327.07 EPS past 5Y4.59% ROI-3.63% 52W High-42.91% Beta1.24
Dividend TTM- Quick Ratio2.07 Sales past 5Y43.88% Gross Margin70.14% 52W Low-1.37% ATR (14)2.80
Dividend Ex-Date- Current Ratio2.32 EPS Y/Y TTM67.92% Oper. Margin-12.20% RSI (14)35.84 Volatility5.49% 3.96%
Employees6600 Debt/Eq0.82 Sales Y/Y TTM19.93% Profit Margin-8.17% Recom1.40 Target Price89.17
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q61.80% Payout- Rel Volume1.61 Prev Close59.49
Sales Surprise1.26% EPS Surprise36.16% Sales Q/Q16.98% EarningsFeb 21 AMC Avg Volume1.82M Price57.53
SMA20-8.35% SMA50-13.51% SMA200-23.73% Trades Volume2,931,799 Change-3.29%
Date Action Analyst Rating Change Price Target Change
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Dec-13-23Initiated Wolfe Research Outperform $95
Oct-10-23Upgrade Piper Sandler Neutral → Overweight $90
Sep-28-23Initiated Bernstein Outperform $83
Aug-02-23Downgrade The Benchmark Company Buy → Hold
May-10-23Upgrade Craig Hallum Hold → Buy $55 → $85
May-05-23Initiated UBS Neutral $73
Mar-09-23Upgrade Citigroup Neutral → Buy $70 → $90
Feb-10-23Downgrade Credit Suisse Outperform → Neutral $50 → $70
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
10:22AM
01:30AM
12:06AM Loading…
12:06AM
Feb-21-24 06:20PM
05:41PM
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
09:00AM Loading…
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
08:05AM Loading…
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
Nov-06-23 09:35AM
Nov-03-23 08:09PM
Nov-02-23 07:23PM
04:02PM
11:03AM
09:40AM
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
Oct-31-23 05:20PM
11:25AM
Oct-30-23 10:20PM
Oct-27-23 08:11PM
Oct-26-23 10:02AM
Oct-25-23 10:02AM
Oct-23-23 08:52PM
Oct-22-23 03:00PM
Oct-20-23 06:08PM
Oct-19-23 02:28PM
09:49AM
Oct-16-23 10:08AM
Oct-12-23 06:00AM
Oct-11-23 08:23AM
Oct-10-23 12:18PM
09:32AM
01:16AM
Oct-09-23 06:00AM
05:58AM
Oct-08-23 07:30AM
Oct-03-23 11:11AM
09:40AM
Oct-02-23 10:45AM
Sep-29-23 09:01PM
Sep-27-23 09:45AM
Sep-22-23 11:28AM
Sep-12-23 08:35AM
Sep-09-23 08:45AM
Sep-07-23 11:50AM
11:14AM
Sep-06-23 11:21AM
Sep-01-23 06:00AM
Aug-31-23 08:28AM
Aug-30-23 07:30AM
Aug-28-23 10:26AM
Aug-21-23 07:57AM
Aug-16-23 09:45AM
Aug-11-23 03:53PM
Aug-10-23 09:37AM
Aug-09-23 07:55PM
02:30PM
Aug-04-23 07:28AM
Aug-03-23 06:07PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOFeb 22Sale59.7811,565691,3561,241,429Feb 23 07:59 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 22Sale59.781,35180,7635,063Feb 23 08:01 PM
Cunningham EverettChief Commercial OfficerFeb 22Sale59.781,35080,70339,270Feb 23 08:00 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 22Sale59.781,09365,3409,767Feb 23 07:57 PM
Condella SarahEVP, Human ResourcesFeb 22Sale59.781,01360,55772,679Feb 23 07:57 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 22Sale59.781,01360,5579,679Feb 23 08:03 PM
COWARD D SCOTTDirectorFeb 22Sale59.7866339,63444,493Feb 23 07:59 PM
Herriott JamesGeneral CounselFeb 22Sale59.7829117,3967,233Feb 23 08:02 PM
Conroy Kevin TPresident and CEOFeb 21Sale61.504,975305,9621,229,756Feb 22 07:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 21Sale61.501,49391,8203,703Feb 22 07:38 PM
Condella SarahEVP, Human ResourcesFeb 21Sale61.501,07966,35871,658Feb 22 07:36 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 21Sale61.501,07866,2978,658Feb 22 07:40 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 21Sale61.5089555,0428,826Feb 22 07:36 PM
COWARD D SCOTTDirectorFeb 21Sale61.5070643,41943,122Feb 22 07:38 PM
Herriott JamesGeneral CounselFeb 21Sale61.5041525,5226,943Feb 22 07:39 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 20Option Exercise0.002,24809,736Feb 22 07:40 PM
Herriott JamesGeneral CounselFeb 20Option Exercise0.0086407,358Feb 22 07:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 20Option Exercise0.003,11205,196Feb 22 07:38 PM
Conroy Kevin TPresident and CEOFeb 20Option Exercise0.0010,37401,234,731Feb 22 07:37 PM
COWARD D SCOTTDirectorFeb 20Option Exercise0.002,248043,828Feb 22 07:38 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 20Option Exercise0.001,72909,721Feb 22 07:36 PM
Condella SarahEVP, Human ResourcesFeb 20Option Exercise0.002,248072,737Feb 22 07:36 PM
Conroy Kevin TPresident and CEOFeb 15Sale61.4314,791908,6111,224,357Feb 16 06:22 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 15Sale61.431,888115,9802,084Feb 16 06:24 PM
COWARD D SCOTTDirectorFeb 15Sale61.431,37684,52841,580Feb 16 06:23 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 15Sale61.4396659,3417,488Feb 16 06:26 PM
Condella SarahEVP, Human ResourcesFeb 15Sale61.4396559,28070,489Feb 16 06:21 PM
Herriott JamesGeneral CounselFeb 15Sale61.4342125,8626,494Feb 16 06:25 PM
Condella SarahEVP, Human ResourcesFeb 14Option Exercise0.002,031071,454Feb 16 06:21 PM
Conroy Kevin TPresident and CEOFeb 14Option Exercise0.0031,13301,239,148Feb 16 06:22 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 14Option Exercise0.002,03108,454Feb 16 06:26 PM
Herriott JamesGeneral CounselFeb 14Option Exercise0.0088306,915Feb 16 06:25 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 14Option Exercise0.003,97203,972Feb 16 06:24 PM
COWARD D SCOTTDirectorFeb 14Option Exercise0.003,972042,956Feb 16 06:23 PM
Condella SarahEVP, Human ResourcesJan 02Sale73.502,000147,00069,423Jan 04 05:19 PM
Baranick BrianGen. Mgr., Precision OncologyJan 02Sale73.5087964,6067,992Jan 04 05:17 PM
Condella SarahEVP, Human ResourcesDec 14Sale70.002,000140,00071,423Dec 18 07:49 PM
Cunningham EverettChief Commercial OfficerOct 12Sale66.4913,007864,83537,909Oct 13 07:59 PM
Cunningham EverettChief Commercial OfficerOct 11Option Exercise0.0027,504050,916Oct 13 07:59 PM
Condella SarahEVP, Human ResourcesSep 01Sale84.364,500379,62075,814Sep 06 04:04 PM
Elliott Jeffrey ThomasChief Financial OfficerAug 21Sale82.9230,2102,505,0130Aug 23 04:08 PM
Baranick BrianGen. Mgr., Precision OncologyAug 07Sale85.041,350114,8048,871Aug 08 04:09 PM
Baranick BrianGen. Mgr., Precision OncologyAug 04Option Exercise0.002,712010,221Aug 08 04:09 PM
Doyle James EdwardDirectorJul 27Sale97.422,000194,84052,110Jul 28 04:06 PM
Herriott JamesGeneral CounselJul 19Sale100.001,300130,0005,964Jul 21 04:04 PM
Zanotti Katherine SDirectorJun 09Sale90.513,027273,97464,629Jun 12 04:17 PM
Doyle James EdwardDirectorJun 09Sale90.511,402126,89554,110Jun 12 04:29 PM
Herriott JamesGeneral CounselJun 08Sale90.001,300117,0007,264Jun 12 04:14 PM
Doyle James EdwardDirectorMay 26Sale80.622,000161,24051,913May 31 04:13 PM
Condella SarahEVP, Human ResourcesMay 10Sale80.006,087486,96080,314May 12 04:11 PM
ORVILLE JACOB AGeneral Manager, ScreeningMay 10Sale80.005,000400,0006,423May 12 04:09 PM
Herriott JamesGeneral CounselMay 10Sale79.851,300103,8058,564May 12 04:07 PM
Condella SarahEVP, Human ResourcesMay 01Sale63.781,00063,78086,401May 03 04:04 PM
Condella SarahEVP, Human ResourcesApr 03Sale67.191,00067,19086,692Apr 05 04:10 PM
ORVILLE JACOB AGeneral Manager, ScreeningMar 03Sale65.005,000325,00011,423Mar 07 04:07 PM
Cunningham EverettChief Commercial OfficerMar 01Sale62.013,628224,97222,703Mar 02 04:07 PM
Condella SarahEVP, Human ResourcesMar 01Sale62.001,00062,00087,692Mar 02 04:05 PM
Conroy Kevin TPresident and CEOFeb 28Sale61.1210,416636,6261,207,306Mar 01 05:15 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 28Sale60.296,832411,87216,423Mar 01 05:22 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale61.124,233258,72129,241Mar 01 05:27 PM
COWARD D SCOTTDirectorFeb 28Sale61.124,153253,83132,775Mar 01 05:19 PM
Condella SarahEVP, Human ResourcesFeb 28Sale61.122,924178,71588,692Mar 01 05:18 PM
Herriott JamesGeneral CounselFeb 28Sale60.432,225134,4539,224Mar 01 05:24 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 28Sale61.121,932118,0847,509Mar 01 05:16 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.009,137033,474Mar 01 05:27 PM
Cunningham EverettChief Commercial OfficerFeb 27Option Exercise0.007,677026,331Mar 01 05:25 PM
Herriott JamesGeneral CounselFeb 27Option Exercise0.001,887011,449Mar 01 05:24 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 27Option Exercise0.003,954023,255Mar 01 05:22 PM
COWARD D SCOTTDirectorFeb 27Option Exercise0.009,194036,928Mar 01 05:19 PM
Condella SarahEVP, Human ResourcesFeb 27Option Exercise0.006,311091,616Mar 01 05:18 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 27Option Exercise0.003,95409,441Mar 01 05:16 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0022,49201,217,722Mar 01 05:15 PM